Related Experiment Video
Updated: Sep 26, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
Arwa Kohela1, Eva van Rooij2,3
1Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, The Netherlands.
Insights
Arrhythmogenic cardiomyopathy involves fibro-fatty tissue replacing heart muscle, leading to arrhythmias. Understanding this process and targeting it may lead to new therapies for sudden cardiac death.
Area of Science:
- Cardiology
- Genetics
- Cell Biology
Background:
- Arrhythmogenic cardiomyopathy (AC) is an inherited heart condition.
- It causes lethal arrhythmias and sudden cardiac death.
- Fibro-fatty tissue replaces heart muscle, worsening cardiac dysfunction.
Purpose of the Study:
- To review models identifying the cellular origin of fibro-fatty tissue in AC.
- To explore molecular pathways of cardiac fibroblast and adipocyte differentiation in AC.
- To discuss therapeutic strategies targeting fibro-fatty remodelling.
Main Methods:
- Review of existing literature and models.
- Analysis of cellular differentiation pathways.
- Discussion of therapeutic targets.
Main Results:
- Various models exist to study AC pathogenesis.
- Key molecular pathways driving fibro-fatty replacement are being identified.
- Targeting fibro-fatty remodelling shows therapeutic potential.
Conclusions:
- Understanding the cellular origins and molecular drivers of fibro-fatty remodelling is crucial for AC.
- Targeting these processes offers a promising avenue for novel AC therapies.
- Further research into AC pathogenesis can reduce sudden cardiac death risk.
Abstract:
Arrhythmogenic cardiomyopathy (AC) is an inherited disorder characterized by lethal arrhythmias and a risk to sudden cardiac death. A hallmark feature of AC is the progressive replacement of the ventricular myocardium with fibro-fatty tissue, which can act as an arrhythmogenic substrate further exacerbating cardiac dysfunction. Therefore, identifying the processes underlying this pathological remodelling would help understand AC pathogenesis and support the development of novel therapies. In this review, we summarize our knowledge on the different models designed to identify the cellular origin and molecular pathways underlying cardiac fibroblast and adipocyte cell differentiation in AC patients. We further outline future perspectives and how targeting the fibro-fatty remodelling process can contribute to novel AC therapeutics.
More Related Videos
09:37Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure
Published on: December 2, 2014
08:31Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction
Published on: July 26, 2018
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Heart Failure II: Pathophysiology
Myocarditis I: Introduction